Skip to Main Content

Paper Details

Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study.
Journal of Clinical Oncology
30
2018
ATM, BRCA1, BRCA1/2, BRCA1/2 mutations, Breast Cancer, Breast cancer, CBC, CHEK2*1100delC, PALB2, Participants, Patients, UBC, Women, breast cancer, cancer, contralateral breast cancer, invasive breast cancer, single-nucleotide polymorphisms, women
Author NameAffiliation
Esther M JohnMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
Charles F LynchMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
John D BoiceMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
Julia A KnightMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
Patrick ConcannonMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
David V ContiMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
Roy E ShoreMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
Daniel O StramMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
Duncan C ThomasMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
Kathleen E MaloneMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
Leslie BernsteinMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
Jonine L BernsteinMemorial Sloan Kettering Cancer Center Mark Robson, Cornell University Roy Shore, New York University School of Medicine, Cancer Prevention Institute of California, and Stanford School of Medicine, University of Southern California, City of Hope National Medical Center, University of Iowa, University of Toronto Julia A. Knight, Danish Cancer Society Research Center, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, University of Florida, University of Cambridge, Translational Genomics Research Institute, Fred Hutchinson Cancer Research Center
  • 1 - 12

Datasets